4//SEC Filing
Quirk Gerald E 4
Accession 0001209191-20-009595
CIK 0001556263other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 4:06 PM ET
Size
5.5 KB
Accession
0001209191-20-009595
Insider Transaction Report
Form 4
Quirk Gerald E
Chief Legal Officer
Transactions
- Award
Stock Option (right to buy)
2020-02-13+94,000→ 94,000 totalExercise: $7.54Exp: 2030-02-12→ Common Stock (94,000 underlying)
Footnotes (1)
- [F1]This option becomes exercisable as to 25% of the shares on February 28, 2021, with the remainder vesting in equal monthly installments of 2.0833% of the shares underlying the award at the end of each successive month thereafter.
Documents
Issuer
Syros Pharmaceuticals, Inc.
CIK 0001556263
Entity typeother
Related Parties
1- filerCIK 0001479603
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 4:06 PM ET
- Size
- 5.5 KB